Innate Immunity Recommendations
To view Article Recommendations, you must have an active subscription.
If your access has expired, you can subscribe at $9.95 per month, the first month of your subscription will be free of charge.
If you think you should be able to access this content, please contact us.
Sign in | Subscribe | Recommend to Library
New to F1000? See this week’s top article below for a free preview of a Recommendation.
SECTION HEADS
-
Laboratory of Developmental Immunology, Merck & Co Inc., Whitehouse Station, NJ, USA
-
Molecular and Cellular Biology Institute, French National Research Agency CNRS, Strasbourg, France
-
Institute of Immunology, University Clinic Schleswig-Holstein, Kiel, Germany
-
Department of Molecular and Cell Biology, University of California, Berkeley, Berkeley, CA, USA
Section Topics
- » Basophil
- » Complement
- » Eosinophils
- » Inflammation & mediators
- » Innate immunity
- » Innate Immunity in lower organisms
- » Intracellular killing
- » Killer cells & killing mechanisms
- » Neutrophils
- » NK cells
- » Opsonization
- » Phagocytosis/scavenging
LATEST RECOMMENDATION
Dean Sheppard, University of California, San Francisco, USA. F1000 Immunology
TOP RATED ARTICLE THIS WEEK [FREE TO VIEW]
5 Recommendations, most recent by
Tom McIntyre, Cleveland Clinic Lerner Research Institute, USA. F1000 Pharmacology & Drug Discovery
- Good for Teaching
- New Finding
- Novel Drug Target
INDIVIDUAL SUBSCRIPTIONS
Get instant access to Article Recommendations from more than 5,000 expert scientists and clinical researchers, assisted by 5,000 associates, by taking out a monthly subscription. The first month of your subscription will be free of charge.
Start your personal subscription today.
Subscribe for $9.95/monthINSTITUTIONAL SUBSCRIPTIONS
Send a recommendation to your institution's librarian or information manager to request an extended free trial for all users.
Recommend to your LibrarianIf you are a librarian or information manager, you may request an extended free trial for your academic or corporate institution.
Request an Institutional Trialyour institution might be eligible for free access via our sponsorship scheme. Check our sponsorship page.
